Genome Therapeutics Ltd

  • Small
  • Active
  • 5 years
  • 4 employees
  • £1,945,129 (assets)
  • Virtual address
  • 4 directors
  • 2 owners
  • Irregular importer

Field of Operation

Research and experimental development on biotechnology
72110 5951 companies

Social media

Summary

Genome Therapeutics Ltd, based in London, UK, is a small, active company founded five years ago. With four employees and £1,945,129 in assets, it operates from a virtual address and is overseen by four directors and two owners. The company is an irregular importer of pharmaceutical products, with just one month of imports recorded in May 2023.

The company's website, Genomics Education Programme, serves as a comprehensive resource for genomics education and training within the UK healthcare workforce. It's not an e-commerce site; instead, it provides a wealth of information, courses, podcasts, and resources for health professionals. The site highlights various initiatives, including a Genomics Conversation, competency frameworks, and career resources, all aimed at embedding genomics knowledge across the NHS. The website also features news, events, and videos, and even a glossary of genomics terms.

Financially, Genome Therapeutics Ltd shows some concerning trends. Cash bank on hand has fallen significantly, dropping 55% to £1.5 million. Current assets have also decreased by 45% to £1.9 million, while net assets have plummeted 48% to £1.7 million. While trade debtors have increased by 75%, suggesting potentially delayed payments, creditors have also risen slightly. The company’s small size (meeting two of three conditions for a small company) means it’s likely exempt from an audit, and the figures are unaudited. The increase in bank borrowings by 2400% is a worrying sign, and the description of the company's situation notes the need for additional funding within the next 12 months, creating a material uncertainty.

Registered in England/Wales under the registration number 12392992, with a registered address at SE19 3HF, United Kingdom, London, Regent House, 316 Beulah Hill.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.

Owners & PSC

  • 5 months
  • 25%+
  • 5 years
  • 1
  • 25%+

Managers

Investor
  • 3 years
Investor
University professor
  • 5 years
  • 299
Secretary

Last reports

Download the last financial report
Download the last confirmation report
* may contain a full shareholder list

Last news

  1. Cancellation of shares. Statement of capital on 2025-01-23
  2. Purchase of own shares.
  3. Notification of Samuel Aparicio as a person with significant control on 2025-01-25
See all events

Importer profile by HS codes

Click on the map to see detailed UK statistics on HS code, including companies list.

Last imported products

Click on items to see detailed UK statistics on HS code, including companies list.

Similar importers

Buy the list of 577 UK B2B buyers of pharmaceutical products.
  • Company names
  • HS codes
  • Financial data
  • Officers and owners
*from 99$

FAQ about Genome Therapeutics Ltd

Looking for leads in the UK?

Try our FREE App—access UK datasets with limited features!

Similar companies